Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.6. Research Assumption
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. Objectives
1.8.1. Objective - 1
1.8.2. Objective - 2
1.8.3. Objective - 3
1.9. List of Secondary Sources
1.10. List of Secondary Sources
Chapter 2. Executive Summary
2.1. U.S. Hormone Therapy (Retail Side) Market
2.1.1. Market Snapshot
2.1.2. Segment Snapshot
2.1.2.1. Product & indication segment outlook
2.1.2.2. Route of administration & distribution channel segment outlook
2.1.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Regulatory Framework
3.5. Business Environment Analysis Tools
3.5.1. Industry Analysis - Porter’s Five Forces Analysis
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrants
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.6. Pricing Analysis in Online vs. Offline Channels
3.7. Consumer Awareness Trends for Hormone Therapy
3.8. Direct-to-Consumer (DTC) Business Models Impact
Chapter 4. Product Business Analysis
4.1. U.S. Hormone Therapy (Retail Side) Market: Product Movement Analysis
4.2. U.S. Hormone Therapy (Retail Side) Market: Product Segment Dashboard
4.3. Product Movement & Market Share Analysis, 2024 & 2033
4.4. U.S. Hormone Therapy (Retail Side) Market Estimates & Forecast, by Product
4.5. Sex Hormones
4.5.1. Sex Hormones Market, 2021-2033 (USD Million)
4.5.2. Estrogen Replacement Therapy (ERT)
4.5.2.1. Estrogen Replacement Therapy (ERT) market, 2021-2033 (USD Million)
4.5.3. Testosterone Replacement Therapy (TRT)
4.5.3.1. Testosterone Replacement Therapy (TRT) market, 2021-2033 (USD Million)
4.5.4. Progesterone Therapy
4.5.4.1. Progesterone therapy market, 2021-2033 (USD Million)
4.5.5. Combined Hormone Therapy
4.5.5.1. Combined hormone therapy market, 2021-2033 (USD Million)
4.6. Thyroid Hormones
4.6.1. Thyroid Hormones Market, 2021-2033 (USD Million)
4.7. Growth Hormones
4.7.1. Growth Hormones Market, 2021-2033 (USD Million)
4.8. Adrenal Hormones
4.8.1. Adrenal Hormones Market, 2021-2033 (USD Million)
4.9. Other Hormones
4.9.1. Other Hormones Market, 2021-2033 (USD Million)
Chapter 5. Indication Business Analysis
5.1. U.S. Hormone Therapy (Retail Side) Market: Indication Movement Analysis
5.2. U.S. Hormone Therapy (Retail Side) Market: Indication Segment Dashboard
5.3. Indication Movement & Market Share Analysis, 2024 & 2033
5.4. U.S. Hormone Therapy (Retail Side) Market Estimates & Forecast, by Indication
5.5. Menopause & Andropause Management
5.5.1. Menopause & Andropause Management Market, 2021-2033 (USD Million)
5.6. Hypothyroidism
5.6.1. Hypothyroidism Market, 2021-2033 (USD Million)
5.7. Hypogonadism
5.7.1. Hypogonadism Market, 2021-2033 (USD Million)
5.8. Growth Hormone Deficiency
5.8.1. Growth Hormone Deficiency Market, 2021-2033 (USD Million)
5.9. Gender Affirming Therapy
5.9.1. Gender Affirming Therapy Market, 2021-2033 (USD Million)
5.10. Fertility Treatment
5.10.1. Fertility Treatment Market, 2021-2033 (USD Million)
5.11. Cosmetic Applications
5.11.1. Cosmetic Applications Market, 2021-2033 (USD Million)
5.12. Other Indications
5.12.1. Other Indications Market, 2021-2033 (USD Million)
Chapter 6. Route of Administration Business Analysis
6.1. U.S. Hormone Therapy (Retail Side) Market: Route of Administration Movement Analysis
6.2. U.S. Hormone Therapy (Retail Side) Market: Route of Administration Segment Dashboard
6.3. Route of Administration Movement & Market Share Analysis, 2024 & 2033
6.4. U.S. Hormone Therapy (Retail Side) Market Estimates & Forecast, by Route of Administration
6.5. Oral
6.5.1. Oral Market, 2021-2033 (USD Million)
6.6. Parenteral
6.6.1. Parenteral Market, 2021-2033 (USD Million)
6.7. Transdermal
6.7.1. Transdermal Market, 2021-2033 (USD Million)
6.8. Other Route of Administration
6.8.1. Other Route of Administration Market, 2021-2033 (USD Million)
Chapter 7. Distribution Channel Business Analysis
7.1. U.S. Hormone Therapy (Retail Side) Market: Distribution Channel Movement Analysis
7.2. U.S. Hormone Therapy (Retail Side) Market: Distribution Channel Segment Dashboard
7.3. Distribution Channel Movement & Market Share Analysis, 2024 & 2033
7.4. U.S. Hormone Therapy (Retail Side) Market Estimates & Forecast, by Distribution Channel
7.5. Offline Retail Pharmacies
7.5.1. Offline Retail Pharmacies Market, 2021-2033 (USD Million)
7.5.2. Large Chains
7.5.2.1. Large chains market, 2021-2033 (USD Million)
7.5.3. Independent Pharmacies
7.5.3.1. Independent pharmacies market, 2021-2033 (USD Million)
7.6. Online Pharmacies / Telehealth
7.6.1. Online Pharmacies / Telehealth Market, 2021-2033 (USD Million)
7.6.2. Pure-Play Online Pharmacies
7.6.2.1. Pure-play online pharmacies market, 2021-2033 (USD Million)
7.6.3. Independent Pharmacies
7.6.3.1. Independent pharmacies market, 2021-2033 (USD Million)
7.7. Telehealth & subscription-based DTC brands
7.7.1. Telehealth & subscription-based DTC brands Market, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization (Offline Pharmacies)
8.2. Company Categorization (Online Pharmacies)
8.3. Company Categorization (Specialized Hormone Clinics)
8.4. Participant’s Overview
8.4.1. Offline Pharmacies
8.4.2. Online Pharmacies
8.4.3. Specialized Hormone Clinics
8.5. Company Market Position Analysis
8.6. Strategy Mapping
8.6.1. Regional Expansion
8.6.2. Mergers & Acquisitions
8.6.3. Others
8.7. Company Profiles/Listing
8.8. Offline Pharmacies
8.8.1. CVS Health
8.8.1.1. Overview
8.8.1.2. Financial performance
8.8.1.3. Product benchmarking
8.8.1.4. Strategic initiatives
8.8.2. Walgreens Boots Alliance, Inc.
8.8.2.1. Overview
8.8.2.2. Financial performance
8.8.2.3. Product benchmarking
8.8.2.4. Strategic initiatives
8.8.3. Walmart Pharmacy
8.8.3.1. Overview
8.8.3.2. Financial performance
8.8.3.3. Product benchmarking
8.8.3.4. Strategic initiatives
8.8.4. Rite Aid Corp
8.8.4.1. Overview
8.8.4.2. Financial performance
8.8.4.3. Product benchmarking
8.8.4.4. Strategic initiatives
8.8.5. The Kroger Co.
8.8.5.1. Overview
8.8.5.2. Financial performance
8.8.5.3. Product benchmarking
8.8.5.4. Strategic initiatives
8.8.6. Albertsons
8.8.6.1. Overview
8.8.6.2. Financial performance
8.8.6.3. Product benchmarking
8.8.6.4. Strategic initiatives
8.8.7. Publix
8.8.7.1. Overview
8.8.7.2. Financial performance
8.8.7.3. Product benchmarking
8.8.7.4. Strategic initiatives
8.8.8. Costco Wholesale Corporation
8.8.8.1. Overview
8.8.8.2. Financial performance
8.8.8.3. Product benchmarking
8.8.8.4. Strategic initiatives
8.8.9. Meijer, Inc.
8.8.9.1. Overview
8.8.9.2. Financial performance
8.8.9.3. Product benchmarking
8.8.9.4. Strategic initiatives
8.9. Online Pharmacies
8.10. Hims & Hers Health, Inc
8.10.1. CVS Health
8.10.1.1. Overview
8.10.1.2. Financial performance
8.10.1.3. Product benchmarking
8.10.1.4. Strategic initiatives
8.10.2. Ro (Roman Health Ventures Inc.)
8.10.2.1. Overview
8.10.2.2. Financial performance
8.10.2.3. Product benchmarking
8.10.2.4. Strategic initiatives
8.10.3. Lemonaid Health, Inc.
8.10.3.1. Overview
8.10.3.2. Financial performance
8.10.3.3. Product benchmarking
8.10.3.4. Strategic initiatives
8.10.4. Mark Cuban Cost Plus Drug Company, PBC
8.10.4.1. Overview
8.10.4.2. Financial performance
8.10.4.3. Product benchmarking
8.10.4.4. Strategic initiatives
8.10.5. Amazon.com, Inc.
8.10.5.1. Overview
8.10.5.2. Financial performance
8.10.5.3. Product benchmarking
8.10.5.4. Strategic initiatives
8.10.6. Blink Health Administration LLC, Inc.
8.10.6.1. Overview
8.10.6.2. Financial performance
8.10.6.3. Product benchmarking
8.10.6.4. Strategic initiatives
8.10.7. GoodRx, Inc
8.10.7.1. Overview
8.10.7.2. Financial performance
8.10.7.3. Product benchmarking
8.10.7.4. Strategic initiatives
8.10.8. Honeybee Health Inc.
8.10.8.1. Overview
8.10.8.2. Financial performance
8.10.8.3. Product benchmarking
8.10.8.4. Strategic initiatives
8.10.9. TruePill
8.10.9.1. Overview
8.10.9.2. Financial performance
8.10.9.3. Product benchmarking
8.10.9.4. Strategic initiatives
8.10.10. NURX Inc.
8.10.10.1. Overview
8.10.10.2. Financial performance
8.10.10.3. Product benchmarking
8.10.10.4. Strategic initiatives
8.10.11. AgelessRx
8.10.11.1. Overview
8.10.11.2. Financial performance
8.10.11.3. Product benchmarking
8.10.11.4. Strategic initiatives
8.11. Specialized Hormone Clinics
8.12. Hims & Hers Health, Inc
8.12.1. BodyLogicMD
8.12.1.1. Overview
8.12.1.2. Financial performance
8.12.1.3. Product benchmarking
8.12.1.4. Strategic initiatives
8.12.2. Defy Medical
8.12.2.1. Overview
8.12.2.2. Financial performance
8.12.2.3. Product benchmarking
8.12.2.4. Strategic initiatives
8.12.3. Renew Vitality
8.12.3.1. Overview
8.12.3.2. Financial performance
8.12.3.3. Product benchmarking
8.12.3.4. Strategic initiatives
8.12.4. Victory Men’s Health
8.12.4.1. Overview
8.12.4.2. Financial performance
8.12.4.3. Product benchmarking
8.12.4.4. Strategic initiatives
8.12.5. Hone Health
8.12.5.1. Overview
8.12.5.2. Financial performance
8.12.5.3. Product benchmarking
8.12.5.4. Strategic initiatives
8.12.6. Joi & Blokes
8.12.6.1. Overview
8.12.6.2. Financial performance
8.12.6.3. Product benchmarking
8.12.6.4. Strategic initiatives
8.12.7. Ways2Well
8.12.7.1. Overview
8.12.7.2. Financial performance
8.12.7.3. Product benchmarking
8.12.7.4. Strategic initiatives
8.12.8. Honeybee Health Inc.
8.12.8.1. Overview
8.12.8.2. Financial performance
8.12.8.3. Product benchmarking
8.12.8.4. Strategic initiatives
8.12.9. 4Ever Young Anti-aging Solutions
8.12.9.1. Overview
8.12.9.2. Financial performance
8.12.9.3. Product benchmarking
8.12.9.4. Strategic initiatives
8.12.10. T CLINICS USA
8.12.10.1. Overview
8.12.10.2. Financial performance
8.12.10.3. Product benchmarking
8.12.10.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. hormone therapy (Retail Side) market, by product, 2021-2033 (USD Million)
Table 4 U.S. Hormone Therapy (Retail Side) Market: Strategy Mapping by Product
Table 5 U.S. hormone therapy (Retail Side) market, by indication, 2021-2033 (USD Million)
Table 6 U.S. Hormone Therapy (Retail Side) Market: Product and Strategy Mapping by Indication
Table 7 U.S. hormone therapy (Retail Side) market, by route of administration, 2021-2033 (USD Million)
Table 8 U.S. Hormone Therapy (Retail Side) Market: Route of Administration and Strategy Mapping by Route of Administration
Table 9 U.S. hormone therapy (Retail Side) market, by distribution channel, 2021-2033 (USD Million)
Table 10 U.S. Hormone Therapy (Retail Side) Market: Distribution Channel and Strategy Mapping by Route of Administration
List of Figures
Figure 1 U.S. hormone therapy (Retail Side) market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Segment outlook
Figure 10 Segment outlook
Figure 11 Competitive landscape
Figure 12 U.S. hormone therapy (Retail Side) market lineage outlook
Figure 13 U.S. hormone therapy (Retail Side) market dynamics
Figure 14 Market driver relevance analysis (Current & future impact)
Figure 15 Market restraint relevance analysis (Current & future impact)
Figure 16 U.S. hormone therapy (Retail Side) market: PESTLE analysis
Figure 17 U.S. hormone therapy (Retail Side) market: Porter’s five forces analysis
Figure 18 U.S. hormone therapy (Retail Side) market: Product segment dashboard
Figure 19 U.S. hormone therapy (Retail Side) market: Product market share analysis, 2024 & 2033
Figure 20 Sex hormones market estimates and forecasts, 2021-2033 (USD Million)
Figure 21 Estrogen Replacement Therapy (ERT) market estimates and forecasts, 2021-2033 (USD Million)
Figure 22 Testosterone Replacement Therapy (TRT) market estimates and forecasts, 2021-2033 (USD Million)
Figure 23 Progesterone therapy market estimates and forecasts, 2021-2033 (USD Million)
Figure 24 Combined hormone therapy market estimates and forecasts, 2021-2033 (USD Million)
Figure 25 Thyroid hormones market estimates and forecasts, 2021-2033 (USD Million)
Figure 26 Growth hormones market estimates and forecasts, 2021-2033 (USD Million)
Figure 27 Adrenal hormones market estimates and forecasts, 2021-2033 (USD Million)
Figure 28 Other hormones market estimates and forecasts, 2021-2033 (USD Million)
Figure 29 U.S. hormone therapy (retail side) market: Indication outlook key takeaways
Figure 30 U.S. Hormone Therapy (Retail Side) Market: Indication Movement Analysis (USD Million)
Figure 31 Menopause & andropause management market estimates and forecasts, 2021-2033 (USD Million)
Figure 32 Hypothyroidism market estimates and forecasts, 2021-2033 (USD Million)
Figure 33 Hypogonadism market estimates and forecasts, 2021-2033 (USD Million)
Figure 34 Growth hormone deficiency market estimates and forecasts, 2021-2033 (USD Million)
Figure 35 Gender affirming therapy market estimates and forecasts, 2021-2033 (USD Million)
Figure 36 Fertility treatment market estimates and forecasts, 2021-2033 (USD Million)
Figure 37 Cosmetic applications market estimates and forecasts, 2021-2033 (USD Million)
Figure 38 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 39 U.S. hormone therapy (retail side) market: Route of administration outlook key takeaways
Figure 40 U.S. Hormone Therapy (Retail Side) Market: Route of Administration Movement Analysis (USD Million)
Figure 41 Oral market estimates and forecasts, 2021-2033 (USD Million)
Figure 42 Parenteral market estimates and forecasts, 2021-2033 (USD Million)
Figure 43 Transdermal market estimates and forecasts, 2021-2033 (USD Million)
Figure 44 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 45 U.S. hormone therapy (retail side) market: Distribution channel outlook key takeaways
Figure 46 U.S. Hormone Therapy (Retail Side) Market: Distribution Channel Movement Analysis (USD Million)
Figure 47 Offline retail pharmacies market estimates and forecasts, 2021-2033 (USD Million)
Figure 48 Large chains market estimates and forecasts, 2021-2033 (USD Million)
Figure 49 Independent pharmacies market estimates and forecasts, 2021-2033 (USD Million)
Figure 50 Online pharmacies / telehealth market estimates and forecasts, 2021-2033 (USD Million)
Figure 51 Pure-play online pharmacies market estimates and forecasts, 2021-2033 (USD Million)
Figure 52 Telehealth & subscription-based DTC brands market estimates and forecasts, 2021-2033 (USD Million)
Figure 53 Others (specialized hormone clinics) market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 Competition categorization (Offline Pharmacies)
Figure 55 Competition categorization (Online Pharmacies)
Figure 56 Competition categorization (Specialized Hormone Clinics)
Figure 57 Company market position analysis
Figure 58 Company market position analysis
Figure 59 Company market position analysis
Figure 60 Strategy mapping
